
Schrödinger Stock: Strong Player In Drug Development Tech
Solskin Schrödinger (NASDAQ:SDGR) is a high-growth drug development company. The company’s long-term revenue is expected to grow at a CAGR of 15% driven by its versatile drug development platform. The company has a robust pipeline […]